116354105	116354105	CD	B-NP	O
|	|	NN	I-NP	O
ACH	ACH	NN	I-NP	O
|	|	NN	I-NP	O
61794617	61794617	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2155292	2155292	CD	B-NP	O
|	|	CC	I-NP	O
1/2/2004	1/2/2004	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Hypotension	Hypotension	NNP	I-NP	O
,	,	,	O	O
NSTEMI	NSTEMI	NNP	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/14/2004	10/14/2004	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/5/2004	10/5/2004	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
URBIETA	URBIETA	NNP	B-NP	O
,	,	,	O	O
MARY	MARY	NNP	B-NP	O
090-64-32-6	090-64-32-6	NNP	I-NP	O
Si	Si	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
RNM	RNM	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
1/5/04	1/5/04	CD	B-NP	O
AT	AT	NN	I-NP	O
11	11	CD	I-NP	O
:	:	:	O	O
15	15	CD	B-NP	O
AM	AM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
VANALSTIN	VANALSTIN	NNP	B-NP	O
,	,	,	O	O
MIKEL	MIKEL	NNP	B-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
COLACE	COLACE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
ENALAPRIL	ENALAPRIL	NNP	I-NP	O
MALEATE	MALEATE	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
hold	hold	VB	B-VP	O
on	on	IN	B-PP	O
mornings	morning	NNS	B-NP	O
of	of	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
2/9/04	2/9/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
DEFINITE	DEFINITE	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-VP	O
ACE	ACE	VB	I-VP	O
INHIBITORS	INHIBITORS	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
following	follow	VBG	B-PP	O
K	K	NNP	B-NP	O
,	,	,	O	O
HD	HD	NNP	B-NP	O
MWF	MWF	NNP	I-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
8/21/04	8/21/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
DEFINITE	DEFINITE	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-VP	O
ACE	ACE	VB	I-VP	O
INHIBITORS	INHIBITORS	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
following	follow	VBG	B-PP	O
k	k	NN	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/21/04	10/21/04	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
DEFINITE	DEFINITE	NN	B-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-VP	O
ACE	ACE	VB	I-VP	O
INHIBITORS	INHIBITORS	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
following	follow	VBG	B-PP	O
k	k	NN	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/21/04	10/21/04	CD	B-NP	O
by	by	IN	B-PP	O
VREELAND	VREELAND	NNP	B-NP	O
,	,	,	O	O
DARIO	DARIO	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DEFINITE	DEFINITE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-VP	O
ACE	ACE	VB	I-VP	O
INHIBITORS	INHIBITORS	NNP	B-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
following	follow	VBG	B-PP	O
k	k	NN	B-NP	O
NPH	NPH	NNP	I-NP	O
HUMULIN	HUMULIN	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
NPH	NPH	NNP	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
;	;	:	O	O
3	3	CD	B-NP	O
UNITS	UNITS	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
SC	SC	NNP	I-NP	O
2	2	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
3	3	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
NTG	NTG	NNP	I-NP	O
1/150	1/150	CD	I-NP	O
-LRB-	-LRB-	SYM	O	O
NITROGLYCERIN	NITROGLYCERIN	NN	B-NP	B-protein
1/150	1/150	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
0.4	0.4	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
Q5MIN	Q5MIN	NN	I-NP	O
X	X	NN	I-NP	O
3	3	CD	I-NP	O
PRN	PRN	NNP	I-NP	O
Chest	Chest	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
ZOCOR	ZOCOR	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/21/04	10/21/04	CD	B-NP	O
by	by	IN	B-PP	O
HASSEL	HASSEL	NNP	B-NP	O
,	,	,	O	O
EDWARDO	EDWARDO	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
NEPHROCAPS	NEPHROCAPS	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
15691306	15691306	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/21/04	10/21/04	CD	B-NP	O
by	by	IN	B-PP	O
GALIPEAU	GALIPEAU	NNP	B-NP	O
,	,	,	O	O
ENRIQUE	ENRIQUE	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
DEFINITE	DEFINITE	NNP	I-NP	O
ALLERGY	ALLERGY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OR	OR	NNP	I-NP	O
SENSITIVITY	SENSITIVITY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
to	to	TO	B-PP	O
HMG	HMG	NN	B-NP	B-protein
CoA	CoA	NN	I-NP	I-protein
REDUCTASE	REDUCTASE	NN	I-NP	I-protein
INHIBITORS	INHIBITORS	VBZ	B-VP	O
Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
md	md	NN	B-NP	O
aware	aware	JJ	B-ADJP	O
,	,	,	O	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
IMDUR	IMDUR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ISOSORBIDE	ISOSORBIDE	NN	I-NP	O
MONONIT	MONONIT	NN	I-NP	O
.	.	.	O	O

-LRB-	-LRB-	NN	B-NP	O
SR	SR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Give	Give	NNP	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-SBAR	O
food	food	NN	B-NP	B-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
NEPHROCAPS	NEPHROCAPS	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
NEPHRO-VIT	NEPHRO-VIT	NNP	I-NP	I-protein
RX	RX	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/21/04	10/21/04	CD	B-NP	O
by	by	IN	B-PP	O
SCHMALZRIED	SCHMALZRIED	NNP	B-NP	O
,	,	,	O	O
EZEQUIEL	EZEQUIEL	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
NIACIN	NIACIN	NNP	I-NP	O
,	,	,	O	O
VIT	VIT	NNP	B-NP	O
.	.	.	O	O

B-3	B-3	NN	B-NP	B-protein
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
NEXIUM	NEXIUM	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
TOPROL	TOPROL	NNP	I-NP	O
XL	XL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SUST	SUST	NNP	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O
-RRB-	-RRB-	NNP	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O

200	200	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	B-NP	O
2	2	CD	I-NP	O
gm	gm	NN	I-NP	O
Na	Na	NN	I-NP	O
/	/	SYM	B-VP	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/day	cals/day	NN	I-NP	O
/	/	SYM	B-NP	O
Low	Low	NN	I-NP	O
saturated	saturate	VBD	B-VP	O
fat	fat	JJ	B-NP	O
low	low	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
/	/	SYM	B-NP	O
Renal	Renal	JJ	I-NP	B-protein
diet	diet	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
FDI	FDI	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
ACTIVITY	ACTIVITY	NNP	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Alan	Alan	NNP	I-NP	O
Mcratt	Mcratt	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
cardiology	cardiology	NN	I-NP	O
at	at	IN	B-PP	O
Lumamer	Lumamer	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
4	4	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
pm	pm	NN	I-NP	O
4/18/04	4/18/04	CD	B-NP	O
scheduled	schedule	VBN	I-NP	O
,	,	,	I-NP	O
Primary	Primary	JJ	I-NP	O
care	care	NN	I-NP	O
physician	physician	NN	I-NP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
Lisinopril	Lisinopril	NNP	B-NP	O
,	,	,	O	O
Zocor	Zocor	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
hmg	hmg	NN	I-NP	O
coa	coa	NN	I-NP	O
reductase	reductase	NN	I-NP	O
inhibitors	inhibitor	NNS	I-NP	O
-RRB-	-RRB-	VBP	B-VP	O
ADMIT	ADMIT	NN	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
hypotension	hypotension	NN	B-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Hypotension	Hypotension	NNP	I-NP	O
,	,	,	O	O
NSTEMI	NSTEMI	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

NIDDM	NIDDM	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

AI/AS	AI/AS	NN	B-NP	O
,	,	,	O	O
bicuspid	bicuspid	JJ	B-NP	O
aortic	aortic	JJ	I-NP	O
valve	valve	NN	I-NP	O
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

HTN	HTN	NN	B-NP	B-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

s/p	s/p	NN	B-NP	B-protein
thyroglossal	thyroglossal	JJ	I-NP	I-protein
duct	duct	NN	I-NP	I-protein
cyst	cyst	NN	I-NP	I-protein
excision	excision	NN	I-NP	I-protein
5	5	CD	I-NP	I-protein
.	.	.	O	O

h/o	h/o	NN	B-NP	O
noncompliance	noncompliance	NN	I-NP	O
with	with	IN	B-PP	O
meds	med	NNS	B-NP	B-protein
6	6	CD	B-NP	I-protein
.	.	.	O	O

3	3	CD	B-NP	O
vessel	vessel	NN	I-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

ESRD	ESRD	NN	B-NP	O
ON	ON	NN	I-NP	O
HD	HD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
end	end	NN	I-NP	O
stage	stage	NN	I-NP	O
renal	renal	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

CHF	CHF	NN	B-NP	B-protein
,	,	,	O	O
unclear	unclear	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
congestive	congestive	JJ	I-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

hyperlipidemia	hyperlipidemia	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
hyperlipidemia	hyperlipidemia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

h/o	h/o	NN	B-NP	O
syphilis	syphilis	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
H/O	H/O	NN	I-NP	O
syphilis	syphilis	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Persantine	Persantine	NNP	I-NP	O
and	and	CC	O	O
viability	viability	NN	B-NP	O
cardiac	cardiac	JJ	I-NP	O
PET	PET	NN	I-NP	O
scan	scan	NN	I-NP	O
4/18/04	4/18/04	CD	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
erate	erate	VB	B-VP	O
global	global	JJ	B-NP	O
LV	LV	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
are	be	VBP	B-VP	O
essentially	essentially	RB	B-ADJP	O
unchanged	unchanged	JJ	I-ADJP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
.	.	.	O	O

CC	CC	NN	B-NP	O
:	:	:	O	O
Hypotension	Hypotension	NN	B-NP	O
after	after	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
56	56	CD	B-NP	O
yo	yo	NN	I-NP	O
male	male	JJ	B-ADJP	O
with	with	IN	B-PP	O
h/o	h/o	NN	B-NP	O
ESRD	ESRD	NNP	I-NP	O
,	,	,	O	O
CAD	CAD	NNP	B-NP	O
,	,	,	O	O
CHF	CHF	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
EF	EF	NNP	I-NP	O
20-25	20-25	CD	I-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
hypotension	hypotension	NN	B-NP	O
after	after	IN	B-PP	O
HD	HD	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
USOH	USOH	NN	I-NP	B-protein
until	until	IN	B-PP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
PTA	PTA	NN	I-NP	B-protein
when	when	WRB	B-ADVP	O
he	he	PRP	B-NP	O
developed	develop	VBD	B-VP	O
stomach	stomach	NN	B-NP	O
upset	upset	NN	I-NP	O
,	,	,	O	O
diarrhea	diarrhea	NN	B-NP	O
,	,	,	O	O
dry	dry	JJ	B-NP	O
heaves	heave	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
dry	dry	JJ	I-NP	O
cough	cough	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
denied	deny	VBD	B-VP	O
recent	recent	JJ	B-NP	O
travels	travel	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
remote	remote	JJ	B-NP	O
Abx	Abx	NN	I-NP	O
use	use	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
Stodun	Stodun	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
5.5	5.5	CD	B-NP	O
liters	liter	NNS	I-NP	O
removed	remove	VBN	B-VP	O
and	and	CC	O	O
afterwards	afterwards	RB	O	O
his	his	PRP$	B-NP	O
BP	BP	NN	I-NP	O
was	be	VBD	B-VP	O
66/30	66/30	CD	B-NP	O
.	.	.	O	O

1	1	CD	B-NP	O
liter	liter	NN	I-NP	O
of	of	IN	B-PP	O
NS	NS	NN	B-NP	B-protein
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
BP	BP	NN	I-NP	O
rose	rise	VBD	B-VP	O
to	to	TO	B-PP	O
73/40	73/40	CD	B-NP	O
.	.	.	O	O

ROS	ROS	NN	B-NP	O
:	:	:	O	O
Chronic	Chronic	JJ	B-NP	O
PND	PND	NN	I-NP	O
,	,	,	O	O
uses	use	VBZ	B-VP	O
1	1	CD	B-NP	O
pillow	pillow	NN	I-NP	O
,	,	,	O	O
gained	gain	VBD	B-VP	O
8kg	8kg	NN	B-NP	O
in	in	IN	B-PP	O
2	2	CD	B-NP	O
weeks	week	NNS	I-NP	O
but	but	CC	O	O
compliant	compliant	JJ	B-ADJP	O
with	with	IN	B-PP	O
meds	med	NNS	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
melena	melena	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
BRBPR	BRBPR	NNP	I-NP	B-DNA
Physical	Physical	NNP	I-NP	I-DNA
Exam	Exam	NNP	I-NP	I-DNA
T	T	NNP	I-NP	I-DNA
97	97	CD	I-NP	I-DNA
p85	p85	NN	I-NP	I-DNA
BP	BP	NN	I-NP	I-DNA
114/67	114/67	CD	I-NP	I-DNA
-	-	HYPH	B-NP	O
>	>	SYM	I-NP	O
160/97	160/97	CD	I-NP	O
rr	rr	JJ	I-NP	O
16-24	16-24	CD	I-NP	O
89	89	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
Chronically	Chronically	RB	B-VP	O
ill	ill	RB	I-VP	O
appearing	appear	VBG	I-VP	O
,	,	,	O	O
NAD	NAD	NNP	B-NP	O
Neck	Neck	NNP	I-NP	O
:	:	:	O	O
Supple	Supple	NNP	B-NP	O
Chest	Chest	NNP	I-NP	O
:	:	:	O	O
Bibasilar	Bibasilar	JJ	B-NP	O
rales	rale	NNS	I-NP	O
CVS	CVS	NN	I-NP	O
:	:	:	O	O
palpable	palpable	JJ	B-NP	O
S3	S3	NN	I-NP	O
,	,	,	O	O
Lat	Lat	NNP	B-NP	B-protein
displaced	displace	VBD	B-VP	O
PMI	PMI	NNP	B-NP	O
,	,	,	O	O
II/VI	II/VI	NNP	B-NP	O
SEM	SEM	NN	I-NP	O
at	at	IN	B-PP	O
RUSB	RUSB	NN	B-NP	B-protein
,	,	,	O	O
JVP	JVP	NN	B-NP	B-protein
<	<	SYM	O	O
7cm	7cm	CD	B-NP	O
Abd	Abd	NNP	I-NP	O
:	:	:	O	O
Soft	Soft	NNP	B-NP	O
NT	NT	NNP	I-NP	O
ND	ND	NNP	I-NP	O
,	,	,	O	O
+	+	NNP	B-NP	O
BS	BS	NNP	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
HSM	HSM	NN	I-NP	B-protein
Ext	Ext	NNP	I-NP	O
:	:	:	O	O
Trace	Trace	NNP	B-NP	O
pedal	pedal	JJ	I-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
hyperpigmentation	hyperpigmentation	NN	B-NP	O
in	in	IN	B-PP	O
sock	sock	NN	B-NP	O
distribution	distribution	NN	I-NP	O
Labs	Lab	NNS	I-NP	O
:	:	:	O	O
WBC	WBC	NN	B-NP	B-protein
5	5	CD	I-NP	I-protein
,	,	,	O	O
TnI	TnI	NN	B-NP	O
0.37	0.37	CD	I-NP	O
,	,	,	O	O
CK	CK	NN	B-NP	B-cell_line
153	153	CD	I-NP	I-cell_line
,	,	,	O	O
CKMB8	CKMB8	NN	B-NP	B-protein
.2	.2	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
chronically	chronically	RB	B-NP	I-protein
elevated	elevated	JJ	I-NP	I-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	O
EKG	EKG	NN	I-NP	O
:	:	:	O	O
NSR	NSR	NN	B-NP	B-protein
,	,	,	O	O
1st	1st	JJ	B-NP	B-protein
deg	deg	NN	I-NP	I-protein
AVB	AVB	NN	I-NP	I-protein
,	,	,	O	O
LAE	LAE	NN	B-NP	B-protein
,	,	,	O	O
LVH	LVH	NN	B-NP	B-protein
,	,	,	O	O
old	old	JJ	B-NP	O
TWI	TWI	NN	I-NP	O
in	in	IN	B-PP	O
1	1	CD	B-NP	O
,	,	,	O	O
L	L	NN	B-NP	O
,	,	,	O	O
V5	V5	NN	B-NP	B-protein
,	,	,	O	O
V6	V6	NN	B-NP	B-protein
,	,	,	O	O
more	more	RBR	B-NP	O
pronounced	pronounced	JJ	I-NP	O
ST	ST	JJ	I-NP	O
dep	dep	NN	I-NP	O
in	in	IN	B-PP	O
V5	V5	NN	B-NP	B-protein
than	than	IN	B-PP	O
9/24	9/24	CD	B-NP	O
CXR	CXR	NN	I-NP	B-protein
:	:	:	O	O
R	R	NN	B-NP	O
pl	pl	NN	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
CMG	CMG	NNP	B-NP	O
Assessment	Assessment	NNP	I-NP	O
:	:	:	O	O
Hypotension	Hypotension	NN	B-NP	O
after	after	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
GI	GI	NN	B-NP	O
upset/diarrhea/vomiting	upset/diarrhea/vomite	VBG	B-VP	O
,	,	,	O	O
likely	likely	RB	B-ADVP	O
was	be	VBD	B-VP	O
dehydrated	dehydrate	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
BP	BP	NN	I-NP	O
rose	rise	VBD	B-VP	O
after	after	IN	B-PP	O
fluids	fluid	NNS	B-NP	O
and	and	CC	O	O
his	his	PRP$	B-NP	O
current	current	JJ	I-NP	O
hypoxia	hypoxia	NN	I-NP	O
is	be	VBZ	B-VP	O
likely	likely	JJ	B-ADJP	O
from	from	IN	B-PP	O
mild	mild	JJ	B-NP	O
pulm	pulm	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Although	Although	IN	B-SBAR	O
chronically	chronically	RB	B-NP	B-protein
elevated	elevated	JJ	I-NP	I-protein
cardiac	cardiac	JJ	I-NP	I-protein
enzymes	enzyme	NNS	I-NP	I-protein
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
concern	concern	NN	B-NP	O
about	about	IN	B-PP	O
new	new	JJ	B-NP	O
ishemia	ishemia	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
concern	concern	NN	B-NP	O
for	for	IN	B-PP	O
PE	PE	NN	B-NP	O
given	give	VBN	B-VP	O
hypoxia	hypoxia	NN	B-NP	O
in	in	IN	B-PP	O
ED	ED	NN	B-NP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
1	1	CD	I-NP	O
.	.	.	O	O

CVS	CVS	NN	B-NP	O
:	:	:	O	O
Ischemia	Ischemia	NN	B-NP	O
:	:	:	O	O
NSTEMI	NSTEMI	NN	B-NP	O
:	:	:	O	O
contined	contine	VBN	B-VP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
with	with	IN	B-PP	O
asa	asa	NN	B-NP	O
,	,	,	O	O
beta	beta	NN	B-NP	O
blocker	blocker	NN	I-NP	O
,	,	,	O	O
imdur	imdur	NN	B-NP	O
,	,	,	O	O
zocor	zocor	NN	B-NP	O
,	,	,	O	O
ntg	ntg	NN	B-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
CkMB	CkMB	NN	I-NP	B-protein
peaked	peak	VBD	B-VP	O
at	at	IN	B-PP	O
12	12	CD	B-NP	O
and	and	CC	O	O
Tni	Tni	NNP	B-NP	O
to	to	TO	B-PP	O
4	4	CD	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
cardiologist	cardiologist	NN	I-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
Dr	Dr	NNP	I-NP	I-protein
Benisek	Benisek	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
recommended	recommend	VBD	B-VP	O
PET	PET	NN	B-NP	O
scan	scan	NN	I-NP	O
to	to	TO	B-VP	O
assess	assess	VB	I-VP	O
for	for	IN	B-PP	O
viable	viable	JJ	B-NP	O
myocardium	myocardium	NN	I-NP	O
and	and	CC	I-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
last	last	JJ	I-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
1	1	CD	I-NP	O
year	year	NN	I-NP	O
ago	ago	RB	B-ADVP	O
showed	show	VBD	B-VP	O
only	only	RB	I-VP	O
scarring	scar	VBG	I-VP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
ischemia	ischemia	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
's	's	POS	B-NP	O
wife	wife	NN	I-NP	O
refused	refuse	VBD	B-VP	O
for	for	IN	B-SBAR	O
him	him	PRP	B-NP	O
to	to	TO	B-VP	O
go	go	VB	I-VP	O
for	for	IN	B-PP	O
CABG	CABG	NN	B-NP	B-protein
.	.	.	O	O

They	They	PRP	B-NP	O
are	be	VBP	B-VP	O
reconsidering	reconsider	VBG	I-VP	O
this	this	DT	B-NP	O
option	option	NN	I-NP	O
currently	currently	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
results	result	NNS	I-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
PET	PET	NN	I-NP	O
scan	scan	NN	I-NP	O
are	be	VBP	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
-	-	HYPH	O	O
A	A	DT	B-NP	O
small	small	JJ	I-NP	O
region	region	NN	I-NP	O
of	of	IN	B-PP	O
myocardial	myocardial	JJ	B-NP	O
scar/hibernation	scar/hibernation	NN	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
mild	mild	JJ	B-NP	O
residual	residual	JJ	I-NP	O
stress	stress	NN	I-NP	O
induced	induce	VBD	B-VP	O
peri-infarct	peri-infarct	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
distribution	distribution	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
Moderate	Moderate	JJ	I-NP	O
global	global	JJ	I-NP	O
LV	LV	NN	I-NP	O
systolic	systolic	JJ	I-NP	O
dysfunction	dysfunction	NN	I-NP	O
.	.	.	O	O

-	-	HYPH	O	O
The	The	DT	B-NP	O
results	result	NNS	I-NP	O
are	be	VBP	B-VP	O
essentially	essentially	RB	B-ADJP	O
unchanged	unchanged	JJ	I-ADJP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
prior	prior	JJ	I-NP	O
study	study	NN	I-NP	O
of	of	IN	B-PP	O
February	February	NNP	B-NP	O
,	,	,	O	O
2003	2003	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
family	family	NN	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
to	to	TO	B-VP	O
stress	stress	VB	I-VP	O
the	the	DT	B-NP	O
importance	importance	NN	I-NP	O
of	of	IN	B-PP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
cardiology	cardiology	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	O	I-protein
They	They	PRP	B-NP	O
have	have	VBP	B-VP	O
missed	miss	VBN	I-VP	O
appointments	appointment	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
-LRB-	-LRB-	SYM	B-NP	O
EF	EF	NN	I-NP	O
20-25	20-25	CD	B-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
enalapril	enalapril	NN	B-NP	O
to	to	TO	B-PP	O
10mg	10mg	CD	B-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
BNP	BNP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
and	and	CC	O	O
pending	pende	VBG	B-NP	O
and	and	CC	I-NP	O
echo	echo	NN	I-NP	O
revealed	reveal	VBD	B-VP	O
EF	EF	NN	B-NP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
Mod	Mod	NNP	B-NP	O
AI	AI	NNP	I-NP	O
.	.	.	O	O

Rhythm	Rhythm	NN	B-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
events	event	NNS	I-NP	O
occurred	occur	VBD	B-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	B-protein
2	2	CD	I-NP	I-protein
.	.	.	O	O

Pulm	Pulm	NNP	B-NP	O
:	:	:	O	O
monitored	monitor	VBN	B-NP	O
sats	sat	NNS	I-NP	O
with	with	IN	B-PP	O
fluid	fluid	NN	B-NP	O
restriction	restriction	NN	I-NP	O
.	.	.	O	O

RA	RA	NN	B-NP	B-protein
sats	sat	NNS	I-NP	I-protein
improved	improve	VBD	B-VP	O
to	to	TO	B-PP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
HD	HD	NN	B-NP	B-protein
MWF	MWF	NN	I-NP	I-protein
,	,	,	O	O
home	home	NN	B-NP	O
renal	renal	JJ	I-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
dialyzed	dialyze	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
below	below	IN	B-PP	O
his	his	PRP$	B-NP	O
previous	previous	JJ	I-NP	O
baseline	baseline	NN	I-NP	O
per	per	IN	B-PP	O
cardiology	cardiology	NN	B-NP	O
recommendations	recommendation	NNS	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
past	past	NN	I-NP	O
he	he	PRP	B-NP	O
has	have	VBZ	B-VP	O
had	have	VBD	I-VP	O
elevated	elevate	VBN	I-VP	O
RH	RH	NN	B-NP	O
filling	filling	NN	I-NP	O
pressures	pressure	NNS	I-NP	O
after	after	IN	B-PP	O
HD	HD	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Ryi	Ryi	NNP	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
attendting	attendte	VBG	I-NP	O
renal	renal	JJ	I-NP	O
physician	physician	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Dr.	Dr.	NNP	I-NP	O
Slemp	Slemp	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
about	about	IN	B-PP	O
his	his	PRP$	B-NP	O
goal	goal	NN	I-NP	O
weight	weight	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Blood	Blood	NN	B-NP	O
cx	cx	NN	I-NP	O
were	be	VBD	B-VP	O
no	no	DT	B-NP	O
growth	growth	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
home	home	NN	I-NP	O
nexium	nexium	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Proph	Proph	NN	B-NP	O
:	:	:	O	O
SQ	SQ	NN	B-NP	O
heparin	heparin	NN	I-NP	O
was	be	VBD	B-VP	O
used	use	VBN	I-VP	O
for	for	IN	B-PP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
very	very	RB	B-ADJP	O
important	important	JJ	I-ADJP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
attend	attend	VBP	B-VP	O
your	your	PRP$	B-NP	O
follow	follow	VB	B-VP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
Dr	Dr	NNP	B-NP	O
Ivrin	Ivrin	NNP	I-NP	O
Please	Please	NNP	I-NP	O
take	take	VB	B-VP	O
the	the	DT	B-NP	O
medications	medication	NNS	I-NP	O
listed	list	VBN	B-VP	O
above	above	IN	B-PP	O
and	and	CC	O	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
take	take	VB	I-VP	O
enalapril	enalapril	NN	B-NP	O
on	on	IN	B-PP	O
mornings	morning	NNS	B-NP	O
of	of	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
Please	Please	NN	I-NP	O
adhere	adhere	JJ	B-ADJP	O
to	to	TO	B-PP	O
your	your	PRP$	B-NP	O
dietary	dietary	JJ	I-NP	O
restrictions	restriction	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
gain	gain	VBP	B-VP	O
more	more	JJR	B-NP	O
than	than	IN	I-NP	O
3	3	CD	I-NP	O
kg	kg	NN	I-NP	O
between	between	IN	B-PP	O
dialysis	dialysis	NN	B-NP	O
sessions	session	NNS	I-NP	O
please	please	VBP	B-VP	O
restrict	restrict	VB	I-VP	O
your	your	PRP$	B-NP	O
fluid	fluid	NN	I-NP	O
intake	intake	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
diet	diet	NN	I-NP	O
guidelines	guideline	NNS	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
coordinated	coordinate	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
staff	staff	NN	I-NP	O
at	at	IN	B-PP	O
Chapmed	Chapmed	NNP	B-NP	O
Gamette	Gamette	NNP	I-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
see	see	VB	B-VP	O
above	above	IN	B-PP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
PASSINO	PASSINO	NNP	B-NP	O
,	,	,	O	O
TERRY	TERRY	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
VO9	VO9	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
1/5/04	1/5/04	CD	I-NP	O
@	@	SYM	B-NP	O
11	11	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

